These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21004219)

  • 21. [COMPLEMENT ACTIVITY IN PATIENTS CONVALESCING FROM TYPHOID FEVER SUBJECTED TO ANTITYPHOID VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYL-PROPIONATE].
    LOSCHIAVO F
    Riforma Med; 1964 Nov; 78():1253-4. PubMed ID: 14231517
    [No Abstract]   [Full Text] [Related]  

  • 22. Duration of postvaccination antityphoid immunity according to the results of strictly controlled field trials.
    Hejfets LB
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(2):154-65. PubMed ID: 5817422
    [No Abstract]   [Full Text] [Related]  

  • 23. [PHAGOCYTIC ACTIVITY AND OPSONIC PROPERTY ILEAL TYPHOID CONVALESCENTS GIVEN ANTITYPHOID VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE].
    LOSCHIAVO F
    Riforma Med; 1964 Sep; 78():1056-8. PubMed ID: 14223406
    [No Abstract]   [Full Text] [Related]  

  • 24. The combined injection of vitamins and vaccines, with a note on typhoid agglutination titres.
    McPHEDRAN FM
    Trans Stud Coll Physicians Phila; 1946 Apr; 14():18. PubMed ID: 20993970
    [No Abstract]   [Full Text] [Related]  

  • 25. A case report of anaphylaxis to Typhoid Vaccine Live Oral Ty21a (Vivotif).
    Haas NL; Haas MRC; Gregory C
    J Travel Med; 2017 Sep; 24(5):. PubMed ID: 28498925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The Sanarelli-Shwartzman phenomenon and serum proteolytic activity].
    GHIRARDO G; GALLO G
    Pathologica; 1960; 52():17-20. PubMed ID: 13704933
    [No Abstract]   [Full Text] [Related]  

  • 27. [The specific resistance produced by typhoid-paratyphoid vaccination compared with the immunity status of former typhoid fever patients as a criterion of evaluation of the effectiveness of T.A.B. vaccine].
    NESTORESCO N
    Arch Roum Pathol Exp Microbiol; 1961 Sep; 20():321-35. PubMed ID: 14479101
    [No Abstract]   [Full Text] [Related]  

  • 28. [The problem of control of anti-typhoid vaccines. V. The immunogenic value of antityphoid vaccines in relation to the antigenic structure of the strains used in their preparation].
    Gabbrielli G; Buzzanca E
    Boll Soc Ital Biol Sper; 1968 Apr; 44(8):725-8. PubMed ID: 5698500
    [No Abstract]   [Full Text] [Related]  

  • 29. Observations on intracutaneous vaccination against typhoid fever.
    BURKHARDT H; DOUGLAS H
    Clinics; 1946 Oct; 5(3):669-77. PubMed ID: 20278547
    [No Abstract]   [Full Text] [Related]  

  • 30. Anaphylactoid reaction to typhoid-paratyphoid A and B vaccine.
    Khan RI
    Trop Geogr Med; 1971 Mar; 23(1):115-6. PubMed ID: 5573579
    [No Abstract]   [Full Text] [Related]  

  • 31. [COMPARATIVE STUDIES ON THE RESISTANCE OF MICE IMMUNIZED WITH TYPHOID O AND VI VACCINES TO THE INFECTION].
    LVOVSKAIA NV
    Biull Eksp Biol Med; 1965 Feb; 59():95-7. PubMed ID: 14273504
    [No Abstract]   [Full Text] [Related]  

  • 32. [OBSISTIN].
    DIMACHE G
    Microbiol Parazitol Epidemiol (Bucur); 1964; 9():129-36. PubMed ID: 14187574
    [No Abstract]   [Full Text] [Related]  

  • 33. [Streptomycin and production of antityphoid agglutinins].
    CAPUTI F
    G Batteriol Immunol; 1950; 41(7-8):369-73. PubMed ID: 15421475
    [No Abstract]   [Full Text] [Related]  

  • 34. Research on the oral antityphoid immunization in mice and its mechanism of action.
    De Barbieri A; Tassi CG; Crovari P; Chiappino G
    Prog Immunobiol Stand; 1970; 4():386-8. PubMed ID: 4991590
    [No Abstract]   [Full Text] [Related]  

  • 35. A study of the immunity against tetanus toxin following the use of a combined typhoid-tetanus vaccine.
    HEGYESSY G; BOZSOKY S; SCHULEK E
    Br J Exp Pathol; 1956 Jun; 37(3):300-5. PubMed ID: 13342355
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies of immunity in typhoid fever. Protection induced by killed oral antigens or by primary infection.
    Dupont HL; Hornick RB; Snyder MJ; Dawkins AT; Heiner GG; Woodward TE
    Bull World Health Organ; 1971; 44(5):667-72. PubMed ID: 5316750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tetanus antitoxin, T.A.B. and seroprotection test in subjects formerly vaccinated with anti-typhoid-paratyphoid A and B, antidiphtheric and antitetanic vaccine (T.A.B.D.T. vaccine)].
    JUDE A; MASSE A
    Rev Immunol Ther Antimicrob; 1951; 15(1-2):20-30. PubMed ID: 14865369
    [No Abstract]   [Full Text] [Related]  

  • 38. [Quantitative and qualitative disorders of the thrombocytes after injection of high molecular polymers. (A contribution to the Sanarelli-Shwartzman phenomenon)].
    RODRIGUEZ-ERDMANN F; LASCH HG
    Thromb Diath Haemorrh; 1961 Apr; 5():518-30. PubMed ID: 13742627
    [No Abstract]   [Full Text] [Related]  

  • 39. [Blood regulation in hypophysectomized dogs following antityphoid vaccination].
    ROMERO E; ROMO ALDAMA E
    Clin Lab (Zaragoza); 1950 Apr; 49(289):294-305. PubMed ID: 15414559
    [No Abstract]   [Full Text] [Related]  

  • 40. [Oral antityphoid vaccination].
    Pontecorvo M
    Riv Ist Sieroter Ital; 1967; 42(4):198-204. PubMed ID: 5596591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.